Lorglumide sodium salt

CAS No. 1021868-76-7

Lorglumide sodium salt( CR-1409 sodium salt )

Catalog No. M26280 CAS No. 1021868-76-7

Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 Get Quote
10MG 65 Get Quote
25MG 107 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lorglumide sodium salt
  • Note
    Research use only, not for human use.
  • Brief Description
    Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
  • Description
    Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CR-1409 sodium salt
  • Pathway
    GPCR/G Protein
  • Target
    Cholecystokinin Receptor
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1021868-76-7
  • Formula Weight
    481.39
  • Molecular Formula
    C22H31Cl2N2NaO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (207.73 mM)
  • SMILES
    CCCCCN(CCCCC)C(=O)C(CCC(=O)O[Na])NC(=O)c1ccc(Cl)c(Cl)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
  • N-Cbz-DL-tryptophan

    N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8.

  • Ceruletide

    Ceruletide is a potent agonist of cholecystokinin receptor and it also is a safe and effective cholecystokinetic agent. It has a direct spasmogenic effect on the gallbladder muscle and bile ducts.Ceruletide is same as biologically and chemically to the human gastrointestinal hormones cholecystokinin-pancreozymin (CCK) and gastrin II.

  • JNJ-26070109

    A novel, potent, selective orally active CCK-2 receptor antagonist with pKi of 8.49 for hCCK2.